Cogent Biosciences
COGT
COGT
69 hedge funds and large institutions have $370M invested in Cogent Biosciences in 2020 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 17 increasing their positions, 9 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
89% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 9
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
Holders
69
Holding in Top 10
6
Calls
–
Puts
–
Top Buyers
| 1 | +$18.1M | |
| 2 | +$16.8M | |
| 3 | +$13.7M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$13.2M |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$12.1M |
Top Sellers
| 1 | -$9.14M | |
| 2 | -$2.82M | |
| 3 | -$1M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$959K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
-$757K |